
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN OR INTO
("
Appointment of Nicola Horlick as Non-Executive Director
Nicola began her career at S.G. Warburg before moving to
In 2004, she founded Bramdean Asset Management, specialising in alternative investments and private equity, and in 2013, founded Money&Co., a fintech lending platform focused on providing capital to
Nicola's deep experience spans equities, fixed income, private capital, alternative assets, and retail and institutional fund distribution. She brings extensive boardroom knowledge and regulatory insight, having served in both executive and non-executive capacities, including as Chair and Committee Member of regulated financial services firms.
Nicola holds a degree in Jurisprudence from
"We are delighted to welcome Nicola to the Board.She brings deep institutional investment experience, extensive governance expertise, and a unique perspective as both an asset management leader and financial innovator. Her appointment strengthens our board at a pivotal time and reinforces our ambition to create long-term value for shareholders."
Nicola Horlick added:
"
Regulatory Disclosures
Pursuant to Listing Rule 9.6.13R,
Current directorships/partner roles:
●
●
●
●
●
●
●
●
●
●
●
● Accelerating Clinical Trials Ltd
●
●
●
●
●
●
●
●
●
●
Past directorships (within the last five years):
●
●
● Money&Co.
For further information you are invited to view the Company's website at www.hamakgold.com or please contact:
|
|
Yellow Jersey PR |
+44 (0) 20 7469 0930
+44 (0) 20 3004 9512 |
About
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the